Qiming Weekly | Qiming Venture Partners Portfolio News & Updates Vol. 33, 2025
Celebrating milestone moments with you at Qiming Venture Partners' portfolio companies
Celebrating milestone moments with you at Qiming Venture Partners' portfolio companies
By constructing a localized private equity valuation framework, FOFWEEKLY aims to advance industry standardization and ultimately establish industry benchmarks that carry social-value leadership.
After raising 100 million RMB from top-tier investors, it abruptly abandoned its core business and went all-in on "AI manhua dramas" — an atypical pivot for an AI startup.
OpenAI's Three Turning Points
New AI Products Incoming: A Quick Look
Liu Xiaopai is an AI entrepreneur who achieved a zero-to-one product breakthrough using the Claude Code tool.
In September 2025, **Triastek, a Dalton Venture portfolio company, received the nation's first Pharmaceutical Manufacturing License for 3D-printed drug production issued by the Jiangsu Provincial Medical Products Administration**. This marks the first time that 3D printing pharmaceutical technology in China has achieved compliant, regulated manufacturing. It represents a critical step forward for Triastek in drug R&D and industrialization, as well as another milestone for Dalton Venture's investments in pharmaceutical innovation.
The World's First Controlling Shareholder to Do Stand-Up Comedy
Models and hardware iterating at breakneck speed
Alibaba Cloud Makes Its First Move Into Embodied Artificial Intelligence